Overview
Interacts with Toll-like receptors (TLR2 and TLR9) on immune cells to activate innate immunity.
Proposed mechanism
Synthetic acetylated polypeptide enhancing cell-mediated immunity by promoting T-cell differentiation and maturation.
What the evidence supports
Human data exists but the trials are small, short-term, or not yet replicated.
Graded Human-limited
Human data that exists but is thin: open-label work, single-arm studies, small cohorts, or observational follow-up without randomisation.
Key citations
Representative primary sources, including results that did not favour the compound.
- [1]
Thymosin alpha-1 in hepatitis B
· DOI:10.1002/14651858.CD008443.pub2 · 2012
- [2]
Immune modulation by TA1
· DOI:10.1080/10245332.2017.1316088 · 2017
- [3]
Thymosin alpha-1 in hepatitis B (2012)
· · 0
- [4]
Immune modulation by TA1 (2017)
· · 0
Citation records in this build are illustrative placeholders for the design.
Reference information for research purposes. Not medical advice, and not a recommendation to use any compound. Many entries describe substances that are not approved for human use.